In the present study, the upregulation of iNOS by post-ischemia treatment with Ast IV was reversed by 2-MeOE2 treatment, which indicates that HIF-1α activation by Ast IV may result in the activation of iNOS signaling and confer protection against myocardial IRI. The gene discussed is HIF1A; the disease is ischemia.